Search research articles
Contact Us
Filters
Showing results (621-630 of 743) with videos related to
Page
of 75
Sort By:
The Prostate
|
May 21, 2008
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations
Jielin Sun, Bao-Li Chang, Sarah D Isaacs, et al.
Genome Biology
|
November 2, 2016
Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23
Amanda McGovern, Stefan Schoenfelder, Paul Martin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 26, 2025
Comparative Effectiveness of Abatacept versus Adalimumab in Shared Epitope positive and negative Rheumatoid Arthritis patients
Chuan Fu Yap, Nisha Nair, Seema D Sharma, et al.
Cerebral Circulation - Cognition and Behavior
|
November 3, 2022
What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?
Anders Wallin, Suvarna Alladi, Sandra E Black, et al.
Cancer Research
|
January 7, 2006
Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function
S Lilly Zheng, Jeong-ho Ju, Bao-li Chang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 12, 2026
Corrigendum to "American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update" [Endocrine Practice. 2026;32(4):473-518]
Susan L Samson, Priyathama Vellanki, Lawrence Blonde, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 23, 2010
Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study
Jose M Gatell, Christine Katlama, Beatriz Grinsztejn, et al.
Arthritis Research & Therapy
|
December 17, 2005
Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B
Ann W Morgan, Jennifer H Barrett, Bridget Griffiths, et al.
Blood
|
October 24, 2002
Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis
Frederique Ponchel, Ann W Morgan, Sarah J Bingham, et al.
Trials
|
May 24, 2017
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial
Mathilde M H Pauls, Natasha Clarke, Sarah Trippier, et al.
Page
of 75
Search research articles
Search
Showing results (621-630 of 743) with videos related to
Sort By:
Page
of 75
The Prostate
|
May 21, 2008
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations
Jielin Sun, Bao-Li Chang, Sarah D Isaacs, et al.
Genome Biology
|
November 2, 2016
Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23
Amanda McGovern, Stefan Schoenfelder, Paul Martin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 26, 2025
Comparative Effectiveness of Abatacept versus Adalimumab in Shared Epitope positive and negative Rheumatoid Arthritis patients
Chuan Fu Yap, Nisha Nair, Seema D Sharma, et al.
Cerebral Circulation - Cognition and Behavior
|
November 3, 2022
What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?
Anders Wallin, Suvarna Alladi, Sandra E Black, et al.
Cancer Research
|
January 7, 2006
Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function
S Lilly Zheng, Jeong-ho Ju, Bao-li Chang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 12, 2026
Corrigendum to "American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update" [Endocrine Practice. 2026;32(4):473-518]
Susan L Samson, Priyathama Vellanki, Lawrence Blonde, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 23, 2010
Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study
Jose M Gatell, Christine Katlama, Beatriz Grinsztejn, et al.
Arthritis Research & Therapy
|
December 17, 2005
Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B
Ann W Morgan, Jennifer H Barrett, Bridget Griffiths, et al.
Blood
|
October 24, 2002
Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis
Frederique Ponchel, Ann W Morgan, Sarah J Bingham, et al.
Trials
|
May 24, 2017
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial
Mathilde M H Pauls, Natasha Clarke, Sarah Trippier, et al.
Page
of 75